Skip to Main Content

Paper Details

Mapping the KRAS proteoform landscape in colorectal cancer identifies truncated KRAS4B that decreases MAPK signaling.
J Biol Chem
6
2023
C, Colorectal Cancer, GFP, KRAS, KRAS gene, KRAS proteoforms, KRAS4A, KRAS4B, KRAS4B proteoforms, MAPK, Truncated KRAS4B, cancer, colorectal cancer, colorectal cancer cell lines, human, oncogenes, tumor
Author NameAffiliation
Caroline J DeHartFrederick National Laboratory for Cancer Research
Lissa C Anderson
Emily S BojaOffice of Cancer Clinical Proteomics Research, National Cancer Institute
Emily S BojaOffice of Cancer Clinical Proteomics Research, National Cancer Institute
Tara HiltkeOffice of Cancer Clinical Proteomics Research, National Cancer Institute
Tara HiltkeOffice of Cancer Clinical Proteomics Research, National Cancer Institute
Christopher L Hendrickson
Henry RodriguezOffice of Cancer Clinical Proteomics Research, National Cancer Institute
Henry RodriguezOffice of Cancer Clinical Proteomics Research, National Cancer Institute
Neil L KelleherNorthwestern University, Northwestern University Feinberg School of Medicine, USA Chemistry of Life Processes Institute
Neil L KelleherNorthwestern University, Northwestern University Feinberg School of Medicine, USA Chemistry of Life Processes Institute
  • 1 - 11

Datasets

Release 1.2